Company Filing History:
Years Active: 2013-2017
Title: Innovations by Swapna Gannabathula
Introduction
Swapna Gannabathula is an accomplished inventor based in Auckland, New Zealand. She has made significant contributions to the field of immunology through her innovative research and development of immunostimulatory compositions. With a total of 3 patents, her work focuses on enhancing or diminishing immune responses using honey-derived compounds.
Latest Patents
Gannabathula's latest patents include "Immunostimulatory compositions and methods of use thereof." This patent describes methods to either enhance or diminish the immune stimulation effects of honey or honey isolates by recognizing the presence of type II arabinogalactan compounds. By tailoring the concentration of these compounds, she adjusts the immune stimulation effects effectively. Another notable patent is "Immunostimulatory compositions and methods of manufacture." This invention outlines immune-stimulatory compositions that exhibit a greater immunostimulatory effect on the immune system than the individual components alone. The compositions include a combination of arabinogalactan protein (AGP) compounds, particularly those derived from honey, along with apisimin proteins, peptides, or functional fragments isolated from royal jelly.
Career Highlights
Throughout her career, Gannabathula has worked with prominent companies such as Comvita New Zealand Limited and Apimed Medical Honey Limited. Her experience in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to advancements in medical honey applications.
Collaborations
Some of her notable coworkers include Jonathan McDonald, Counsell Stephens, and Ian Sims. Their collaboration has further enriched her research and development efforts in the field of immunology.
Conclusion
Swapna Gannabathula's contributions to immunology through her patents and collaborations highlight her role as a leading inventor in her field. Her innovative approaches to enhancing immune responses through honey-derived compounds are paving the way for future advancements in medical applications.